Dryden Capital, LLC - EUROPEAN BIOTECH ACQUTN CORP ownership

Back to all holdings Add to watchlist

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 32 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Dryden Capital, LLC ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$4,470–15,0000.0%0.01%–
Q3 2022$0
-100.0%
15,0000.0%0.00%
-100.0%
Q2 2022$1,000
-66.7%
15,0000.0%0.00%
-50.0%
Q1 2022$3,000
-66.7%
15,0000.0%0.00%
-66.7%
Q4 2021$9,000–15,000–0.01%–
 Download
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders